Bergamo, Italy : 5 - 7 November 2018
After two highly-rated previous editions, the 3rd EACR conference on the topic of personalised medicine will update you on the latest challenges and advances in targeted and immunological cancer therapies. It will cover a broad spectrum of basic, translational and clinical research, all related to currently pressing questions relevant across cancer types.
The multidisciplinary programme will encompass developments in diagnosis and early detection, including novel bioinformatic approaches. New immuno-oncology treatments will also be presented, emphasising the role of the tumour microenvironment and showcasing systems immunology. The emergence and role of drug-tolerant tumour fractions will be discussed in the context of drug resistance. And, reflecting one of the major needs, there will be a focus on rational design of combinatorial therapies and on how advances emerging from the laboratory are clinically implemented.
The programme includes 17 plenary lectures, dedicated poster sessions and interactive elements. The small size of the conference makes it an excellent forum to share new data, and to network with colleagues and speakers.
We welcome all basic, translational and clinical scientists (including postdocs and trainees), who are interested in tackling pressing cancer-relevant questions, and who want to hear the latest developments in therapies targeting cancer and immune cells. We also invite industry scientists who are interested in targets for novel therapies. This is an excellent forum for informal networking and meeting potential collaborators.
Johanna Joyce SWITZERLAND, Richard Marais UK, Daniel Peeper (chair) NETHERLANDS, Ze'ev Ronai ISRAEL / USA
Bursary application deadline:
03 September 2018
Abstract submission deadline:
03 September 2018
01 October 2018
- participant feedback from the last edition of the meeting
98% of the participants from the last edition would recommend the conference to others.
This is considered an out of date browser. This website has been developed with modern browsers in mind to allow it to display at its best in a wide variety of viewing situations - including mobile viewing. But we haven't supported older browsers like IE8. Please upgrade to the latest version of Internet Explorer - or try Mozilla Firefox or Google Chrome. Both are excellent browsers.